297 related articles for article (PubMed ID: 30234458)
21. Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.
Mollà M; Saez J; Ramos M; Giraldo A; Seoane A; Andreu J; Simó M; Giralt J
Br J Radiol; 2016 Jun; 89(1062):20150824. PubMed ID: 26986457
[TBL] [Abstract][Full Text] [Related]
22. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma.
Liu F; Brown DR; Munley MT
Radiother Oncol; 2024 May; 194():110223. PubMed ID: 38467342
[TBL] [Abstract][Full Text] [Related]
23. Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.
Brada M; Forbes H; Ashley S; Fenwick J
J Thorac Oncol; 2022 Apr; 17(4):532-543. PubMed ID: 35092841
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
25. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the invasion of lymphocytes and cytokines in the tumor microenvironment and the interval after single brachytherapy hypofractionated radiotherapy and conventional fractionation radiotherapy in non-small cell lung Cancer.
Li L; Yue HC; Han YW; Liu W; Xiong LG; Zhang JW
BMC Cancer; 2020 Sep; 20(1):893. PubMed ID: 32942998
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the biological effects of 125I seeds continuous low-dose-rate radiation and 60Co high-dose-rate gamma radiation on non-small cell lung cancer cells.
Wang Z; Zhao Z; Lu J; Chen Z; Mao A; Teng G; Liu F
PLoS One; 2015; 10(8):e0133728. PubMed ID: 26266801
[TBL] [Abstract][Full Text] [Related]
28. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
29. Clinically validated model predicts the effect of intratumoral heterogeneity on overall survival for non-small cell lung cancer (NSCLC) patients.
Ghaderi N; Jung JH; Odde DJ; Peacock J
Comput Methods Programs Biomed; 2021 Nov; 212():106455. PubMed ID: 34736167
[TBL] [Abstract][Full Text] [Related]
30. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.
Appelt AL; Vogelius IR; Bentzen SM
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):147-52. PubMed ID: 22910644
[TBL] [Abstract][Full Text] [Related]
31. Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer.
Singer JM; Price P; Dale RG
Br J Cancer; 1998 Dec; 78(12):1629-33. PubMed ID: 9862575
[TBL] [Abstract][Full Text] [Related]
32. Effect of reoxygenation on hypofractionated radiotherapy of prostate cancer.
Kuperman VY; Lubich LM
Med Phys; 2020 Oct; 47(10):5383-5391. PubMed ID: 32583529
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
[TBL] [Abstract][Full Text] [Related]
34. Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results From the Randomized Phase III HYPRO Trial.
Wortel RC; Pos FJ; Heemsbergen WD; Incrocci L
J Sex Med; 2016 Nov; 13(11):1695-1703. PubMed ID: 27665195
[TBL] [Abstract][Full Text] [Related]
35. A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer.
Cagney DN; Thirion PG; Dunne MT; Fleming C; Fitzpatrick D; O'Shea CM; Finn MA; O'Sullivan S; Booth C; Collins CD; Buckney SJ; Shannon A; Armstrong JG
Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):30-38. PubMed ID: 29097074
[TBL] [Abstract][Full Text] [Related]
36. A radiobiological model of reoxygenation and fractionation effects.
Guerrero M; Carlson DJ
Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated irradiation for non-small cell lung cancer.
Abratt RP; Bogart JA; Hunter A
Lung Cancer; 2002 Jun; 36(3):225-33. PubMed ID: 12009230
[TBL] [Abstract][Full Text] [Related]
38. Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model.
Lüdeking M; Stemwedel K; Ramachandran D; Grosche S; Christiansen H; Merten R; Henkenberens C; Bogdanova NV
Front Oncol; 2024; 14():1293745. PubMed ID: 38720797
[TBL] [Abstract][Full Text] [Related]
39. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
[TBL] [Abstract][Full Text] [Related]
40. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
